Adaptimmune Therapeutics Plc OverviewAdaptimmune Therapeutics Plc Net Income
Profitability analysis for ADAP.
Quarterly Net Income
-$30.34M
↓ 143.59% YoY
As of Jun 2025
Annual Net Income (TTM)
-$169.76M
↓ 133.06% YoY
Trailing 12 months ending Jun 2025
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...